Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan

OBJECTIVES: The prevalence of pediatric Crohn’s disease (CD) is increasing in Japan and other countries, and many patients are unresponsive to or do not tolerate current treatment options. This study aimed to investigate the efficacy, safety, and pharmacokinetic profile of infliximab (IFX) in pediat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajiri, Hitoshi, Motoya, Satoshi, Kinjo, Fukunori, Maemoto, Atsuo, Matsumoto, Takayuki, Sato, Noriko, Yamada, Hiroshi, Nagano, Mieko, Susuta, Yutaka, Ozaki, Kunihiko, Kondo, Kazuoki, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095542/
https://www.ncbi.nlm.nih.gov/pubmed/30114224
http://dx.doi.org/10.1371/journal.pone.0201956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095542/
https://www.ncbi.nlm.nih.gov/pubmed/30114224
http://dx.doi.org/10.1371/journal.pone.0201956

Ejemplares similares